Photopharmics
Manufacturing · Utah, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3451 N Triumph Blvd Ste 201, Lehi, Utah,...Phone Number
(801) 770-6960Website
www.photopharmics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Photopharmics
PhotoPharmics is a pioneer in specialized phototherapy aimed at treating neurodegenerative diseases, particularly Parkinson's disease. Their personalized at-home device, Celeste specialized phototherapy, addresses both motor and non-motor symptoms, showing promising results in clinical studies. The company targets individuals living with Parkinson's, offering a new therapeutic approach that enhances quality of life without major side effects. Future plans include expanding their innovative solutions to Alzheimer's and other neurodegenerative conditions.Explore more
Photopharmics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Photopharmics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Photopharmics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Photopharmics
Check out if Photopharmics is spiking on competitors!
Product Launch: Get notified when Photopharmics launches new products
Photopharmics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Photopharmics has new funding data
Click to see if Photopharmics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Photopharmics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Photopharmics
Find 2 more new buyers
Compare Similar Companies to Photopharmics
Compare insights from companies similar to Photopharmics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Photopharmics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Photopharmics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Photopharmics.
Photopharmics financials insights
Gather financial insights about Photopharmics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$2.1M
2017
Private Equity
$2.3M
Debt
$2.6M
2023
Other Financing Round
$18M
2025
Other Financing Round
$6M
Photopharmics Tech Stack
A closer look at the technologies used by Photopharmics
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
Photopharmics News & Media
PhotoPharmics to Participate in AAN Annual Meeting as Phase 3 Light for PD Trial Nears Completion
Company available for scientific exchange as pivotal study approaches completion. Data Readout Anticipated at World Parkinson Congress. SALT LAKE CITY, UT, UNITED STATES, April 16, 2026 /EINPresswire.com/ -- PhotoPharmics, a clinical-stage medical …PhotoPharmics Announces Board Expansion to Support Growth: Clinical, Commercialization and Strategic Partnerships
SALT LAKE CITY, UT, UNITED STATES, December 4, 2025 /EINPresswire.com/ -- PhotoPharmics, a clinical-stage medical device company developing photo-neuromodulation therapies for neurodegenerative diseases today announced the addition of two widely …PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote “Light for PD” Clinical Trial
SALT LAKE CITY, UT, UNITED STATES, November 6, 2025 /EINPresswire.com/ -- PhotoPharmics, a clinical-stage medical device company pioneering Photo Neuromodulation for neurodegenerative disease, today announced it has surpassed its enrollment target with …PhotoPharmics Assembles All-Star Advisory Board to Propel Celeste Toward FDA Market Launch
PhotoPharmics (American Fork, UT) advances commercialization of Celeste®, its FDA Breakthrough-designated Parkinson’s device, by forming a Commercial Advisory Board, adding executive talent, and surpassing clinical milestones, strengthening Utah’s medtech leadership on a global stage.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Photopharmics
Sign Up For FreeTo access detailed company insights
PhotoPharmics is a pioneer in specialized phototherapy aimed at treating neurodegenerative diseases, particularly Parkinson's disease. Their personalized at-home device, Celeste specialized phototherapy, addresses both motor and non-motor symptoms, showing promising results in clinical studies. The company targets individuals living with Parkinson'... Read More
